Objective(s)—To characterize the variations in normal cervical spectra due to menopausal status and location within the menstrual cycle. Using the information obtained, the accuracy of Raman Spectroscopy to diagnose low grade squamous intraepithelial lesion (LGSIL) will be improved. Study Design—A total of 133 patients undergoing either colposcopy or Pap smear were recruited from either Vanderbilt University or Tri-State Women’s Health. Raman spectra were collected from both normal and diseased areas. The data was processed and analyzed using a multi-class discrimination and classification algorithm to determine if the spectra can be correctly classified. Results—Stratifying the data by menopausal state resulted in correctly classifying of ...
International audienceCervical cancer is the fourth most common cancer in women worldwide and mainly...
Early detection of malignant tumours, or their precursor lesions, improves patient outcome. High ris...
Cervical cancer is the third most common cancer affecting women worldwide. The mortality associated ...
Cervical cancer is the second most common malignancy among women worldwide, with over 490 000 cases ...
In this paper, we examine how variations in normal tissue can influence disease classification of Ra...
Many groups have used Raman spectroscopy for diagnosing cervical dysplasia; however, there have been...
Raman spectroscopy is a powerful tool that has the potential to be used as a screening method for ce...
Cervical cancer is the second commonest cancer in women worldwide. Over the last decade, our lab has...
The aim of the study was to develop a method of detecting cervical cancer using Raman spectroscopy i...
Raman spectroscopy has the potential to differentiate among the various stages leading to high-grade...
International audienceCervical cancer is the third most common cancer affecting women worldwide. The...
The authors present Raman cluster mapping of de-paraffinized normal cervical tissue and demonstrate ...
The authors present Raman cluster mapping of de-paraffinized normal cervical tissue and demonstrate ...
The mortality associated with cervical cancer can be reduced if detected at the precancer stage, but...
Early detection of malignant tumours, or their precursor lesions, can dramatically improve patient o...
International audienceCervical cancer is the fourth most common cancer in women worldwide and mainly...
Early detection of malignant tumours, or their precursor lesions, improves patient outcome. High ris...
Cervical cancer is the third most common cancer affecting women worldwide. The mortality associated ...
Cervical cancer is the second most common malignancy among women worldwide, with over 490 000 cases ...
In this paper, we examine how variations in normal tissue can influence disease classification of Ra...
Many groups have used Raman spectroscopy for diagnosing cervical dysplasia; however, there have been...
Raman spectroscopy is a powerful tool that has the potential to be used as a screening method for ce...
Cervical cancer is the second commonest cancer in women worldwide. Over the last decade, our lab has...
The aim of the study was to develop a method of detecting cervical cancer using Raman spectroscopy i...
Raman spectroscopy has the potential to differentiate among the various stages leading to high-grade...
International audienceCervical cancer is the third most common cancer affecting women worldwide. The...
The authors present Raman cluster mapping of de-paraffinized normal cervical tissue and demonstrate ...
The authors present Raman cluster mapping of de-paraffinized normal cervical tissue and demonstrate ...
The mortality associated with cervical cancer can be reduced if detected at the precancer stage, but...
Early detection of malignant tumours, or their precursor lesions, can dramatically improve patient o...
International audienceCervical cancer is the fourth most common cancer in women worldwide and mainly...
Early detection of malignant tumours, or their precursor lesions, improves patient outcome. High ris...
Cervical cancer is the third most common cancer affecting women worldwide. The mortality associated ...